Position in ALKS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$30,022
+$9,761 QoQ
Shares Held
573
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#344
of 421 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NBC SECURITIES, INC. holds $2,443,856 across 16 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
18,003 | $1,293,695 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
52,488 | $841,382 | |
| 3 | PRGO |
PERRIGO Co plc
|
15,094 | $156,826 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,000 | $80,000 | |
| 5 | ALKS |
Alkermes plc.
This page
|
573 | $30,022 | |
| 6 | HROW |
Harrow, Inc.
|
412 | $17,497 | |
| 7 | VTRS |
Viatris Inc
|
557 | $8,845 | |
| 8 | HLN |
Haleon plc
|
882 | $8,229 |
All Filings in ALKS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,022 | 573 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $20,261 | 573 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $16,032 | 573 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $8,400 | 280 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,010 | 280 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $9,245 | 280 | Shares | Sole | 2025-04-09 | |
| 2024-09-30 | $12,147 | 434 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $10,459 | 434 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $6 | 253 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $7,018 | 253 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||